We find that CASZ1 directly regulates MRFs, expression of skeletal muscle genes, and myogenic differentiation in normal myoblasts and acts as a key component of the CRC that enables ERMS to differentiate when treated with MEK inhibitor. This evidence concerns the gene MAP2K7 and colorectal carcinoma.